The use of gabapentin enacarbil in the treatment of restless legs syndrome. - Wikidata - wikimedia - TriplyDB

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

http://www.wikidata.org/entity/Q34409544

about

Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice.Gabapentin enacarbil: in patients with restless legs syndrome.ADMET considerations for restless leg syndrome drug treatments.Gabapentin enacarbil: pharmacotherapy of restless legs syndrome ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.Sleep dysfunction and its management in Parkinson's disease.Restless legs syndrome: pathophysiology and treatment.Parkinson's disease and sleep/wake disturbances

P2860

Q28585548-4CB87079-93C5-41AA-AB17-440C026ED405 Q34313624-7AB87E10-EDBC-4993-826A-DB4FB04ED636 Q38027180-ACED85CD-41A6-4DBE-96BE-1F44F4FD48B2 Q38122149-BD2B3300-1A5E-4935-84B2-9185BEE88273 Q38242390-D639EB10-C829-480A-B581-11B1307F08D0 Q41819301-E1A266A2-85DE-48E3-B731-3F2B78A83A91 Q48028994-4F99EA51-3FB4-4ADF-8040-6FB01204C3EA Q58913404-A409AC4A-0C43-453D-A038-37C52FC6B559

P2860

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

http://www.wikidata.org/entity/Q34409544

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@ast

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@en

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@nl

type

label

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@ast

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@en

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@nl

prefLabel

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@ast

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@en

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@nl

P1433

Q34409544-64908716-0E5F-4E97-A586-23384CEB9C88

P1476

Q34409544-9B96CF2D-949D-4034-A6BB-6F44674E7E87

P2093

Q34409544-DD0DAAB5-084C-499A-B193-4F8AFF74CC04

Q34409544-F8F0290C-D5E7-4BB0-8134-55ACE2BCD6B3

P2860

Q34409544-03CC5DAC-0F9A-45F8-B919-031BA6E11D54

Q34409544-134BC3FB-3EC7-4DD5-B023-819741D874E9

Q34409544-1D1C5869-CCF1-4590-ABD5-6DC0A1D7CDBD

Q34409544-2B84D2E4-1A2A-4EC4-91FF-1F513F29C176

Q34409544-2E3C5807-1934-4DE8-B556-82BDE100B4D3

Q34409544-3124082C-D7FF-41B8-BD67-DEC9BD58683B

Q34409544-43480F6B-05E7-44B6-A10E-4FCA210822B2

Q34409544-44082E0A-176B-4D88-8125-2594FD241926

Q34409544-44638CD7-916B-4AEA-B8D8-60A7011CE8D6

Q34409544-505A5B02-F606-48F5-8C2D-94F9B1D8B0A4

P304

Q34409544-F6EFECF5-1C9F-4ED1-8D3C-BBCEE8242D7C

P31

Q34409544-6bba2c51-bd8e-4be5-80ae-ba3f99d98156

Q34409544-AF219C0C-D939-46F9-BB26-4A314DFABD64

P356

Q34409544-E6F40080-BC29-4030-987D-41D6A47470AE

P433

Q34409544-D6A2172E-58F2-4EAC-B110-6F0B25373BBC

P478

Q34409544-DE1DC13E-8550-4112-BD03-ECD90EF5F1B0

P577

Q34409544-E1BBD8D9-6C31-451D-85CD-C93C1BA89B31

P5875

Q34409544-9B2DBB7C-3B05-433C-ABB6-BEA1DCA4FCB1

P698

Q34409544-610EF855-51CA-4A5C-A809-BDC7E65A8B3B

P921

Q34409544-72B16885-EA3B-4B29-824A-CBB1241D0754

Q34409544-88F0AB42-69F9-4132-8F4C-5CC535252751

Q34409544-8B7494C7-99D1-4FAE-8C4F-514EBF8B2853

P932

Q34409544-650B2789-A64E-4B73-B2FB-441F17866281

P356

1756285610378059

P1433

Therapeutic advances in neurological disorders

P1476

The use of gabapentin enacarbil in the treatment of restless legs syndrome.

@en

P2093

Toby C Yaltho

http://www.w3.org/2001/XMLSchema#string

William G Ondo

http://www.w3.org/2001/XMLSchema#string

P2860

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Restless legs syndrome and sleep bruxism: prevalence and association among Canadians.

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters.

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkey

Restless legs syndrome prevalence and impact: REST general population study.

Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.

Restless legs syndrome: clinicoetiologic correlates.

Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin.

A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.

P304

269-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756285610378059

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49703595

http://www.w3.org/2001/XMLSchema#string

P698

21179617

http://www.w3.org/2001/XMLSchema#string

P921

gabapentin enacarbil

restless legs syndrome

P932

3002665

http://www.w3.org/2001/XMLSchema#string